dailynewsnblog
Robin LaChapelle joins Elysian as a strategic advisor with extensive experience in strategy, operations, and organizational leadership across financial services, technology, and other highly regulated industries. In her advisory capacity, LaChapelle will lend her knowledge in scaling organizations, strategic planning, and enterprise restructuring to assist Elysian in its next phase of growth. She currently serves as Chief Operating Officer and Co-Founder of ArriVent BioPharma, an oncology-focused biotechnology company, where she leads HR, IT, Communications, and Facilities. Previously, LaChapelle served as an Executive Advisor at RLT Consulting, held senior executive positions at MedImmune and AstraZeneca, Lockheed Martin, Capital One, and Bank of America.
